CLB-TRANSFECTION
LIVE

Serial Number

79074723

Owner

Lonza Cologne GmbH

Attorney

David M. Perry

Filing Date

Aug 28, 2009

Add to watchlist:

No watchlists yet
View on USPTO

CLB-TRANSFECTION Trademark

Serial Number: 79074723 • Registration: 3790467

CLB-TRANSFECTION is a trademark filed by Lonza Cologne GmbH on August 28, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

Lonza Cologne GmbH (12 trademarks)

Nattermannallee 1
50829 Köln , DE

Entity Type: 98

LONZA COLOGNE AG (12 trademarks)

KOELN 50829 , DE

Entity Type: 09

Trademark Details

Filing Date

August 28, 2009

Registration Date

May 18, 2010

Published for Opposition

March 2, 2010

Cancellation Date

August 28, 2019

Goods & Services

Scientific apparatus and instruments, namely, electrical equipment in the nature of electrical field generators and capacitor impulse generators for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins; apparatus and instruments for electroporation, namely, electroporators and their peripheral equipment; apparatus and instruments for conducting, switching, converting, storing, controlling and monitoring of electricity, namely, electrical capacitors, electrical conductors and contacts, power semiconductors, transistors, relays, transformers, and electric parameter monitor modules; laboratory equipment and supplies, namely, devices, containers and reaction vessels for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins; test tubes; electrodes made of metal and conductive polymers; cuvettes, namely, test tubes having electrodes made of metal and conductive polymers for biochemical purposes; multi-well plates having electrodes made of metal and conductive polymers for biochemical purposes; data processors and computers; computer peripherals; computer programs and software recorded on data media designed for use in controlling of scientific apparatus and instruments for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins

Pharmaceutical preparations for the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; diagnostic preparations for medical and veterinary use; living cells for medical or clinical use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; cultures of microorganisms, namely, bacterial and viral preparations for medical or clinical use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; proteins, peptides, nucleic acid sequences and biochemical reagents of these molecules for medical and veterinary use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer

Chemical and biochemical preparations used in industry and science for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins; buffer and standard solutions for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins, for scientific and research use; chemical preparations for scientific purposes in the nature of laboratory chemicals for cell culture, namely, aqueous solutions containing nutrients for cultivating living cells; biological agents, namely, buffer and standard solutions containing living cells, proteins, peptides and/or nucleic acid molecules for laboratory use other than for medical and veterinary purposes; diagnostic preparations other than for medical and veterinary purposes; biological reagents for laboratories, namely, peptides, proteins, nucleic acids and complexes made of peptides, proteins and/or nucleic acids, for scientific and research use, namely, for detecting gene expression and localizing proteins as well as for integrating foreign nucleic acids into the genome of living cells and transient production of proteins for laboratory use; chemicals for use in science to transfer foreign genetic material into another cell, namely, nucleic acid molecules in the nature of expression and control vectors for laboratory use; biochemical reagents for non-medical purposes commonly known as transfection reagents for transient production of proteins for laboratory use

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Mar 27, 2020 DENC
DEATH OF INTERNATIONAL REGISTRATION
Mar 27, 2020 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Sep 29, 2017 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 28, 2017 INTS
INVALIDATION PROCESSED
Aug 28, 2017 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 23, 2017 INTR
CANCELLED SECTION 71
Dec 23, 2016 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 18, 2015 REM3
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jan 9, 2013 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Dec 29, 2012 CRCV
NEW REPRESENTATIVE AT IB RECEIVED
Aug 3, 2012 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 11, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 11, 2011 REAP
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 5, 2011 ADCH
REGISTERED-PRINCIPAL REGISTER
May 18, 2010 R.PR
PUBLISHED FOR OPPOSITION
Mar 2, 2010 PUBO
NOTICE OF PUBLICATION
Feb 10, 2010 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 28, 2010 PREV
ASSIGNED TO LIE
Jan 28, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2010 CNSA
ASSIGNED TO EXAMINER
Dec 3, 2009 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 2, 2009 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 28, 2009 NWOS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Nov 27, 2009 LIMS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 26, 2009 REPR